PEPFAR at 20
First proposed by President Bush in January, 2003, and approved by Congress in late May, 2003, PEPFAR has since received more than $100 billion in US Government support. According to the US State Department, over a dozen countries with high disease burden have HIV under control thanks to PEPFAR. (Ph...
Gespeichert in:
| Veröffentlicht in: | The Lancet (British edition) 2023-04, Vol.401 (10383), p.1145-1146 |
|---|---|
| 1. Verfasser: | |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1146 |
|---|---|
| container_issue | 10383 |
| container_start_page | 1145 |
| container_title | The Lancet (British edition) |
| container_volume | 401 |
| creator | Webster, Paul |
| description | First proposed by President Bush in January, 2003, and approved by Congress in late May, 2003, PEPFAR has since received more than $100 billion in US Government support. According to the US State Department, over a dozen countries with high disease burden have HIV under control thanks to PEPFAR. (Photo by Paul Botes / AFP) (Photo by PAUL BOTES/AFP via Getty Images) Paul Botes/Getty Images Jennifer Kates, Director of Global Health and HIV Policy at the Kaiser Family Foundation, Washington DC, says that data from two studies she coauthored show a “strong, significant association between PEPFAR and progress in many health indicators beyond HIV”. González-Pier describes PEPFAR now as a “maintenance programme” that should increasingly expect to share the stage with other US international health priorities including climate change, global health security, and pandemic control. “Because PEPFAR proved itself so successfully, cross-cutting lessons are now being drawn from it for a new set of US health diplomacy concerns”, says González-Pier. |
| doi_str_mv | 10.1016/S0140-6736(23)00717-1 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2799172261</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0140673623007171</els_id><sourcerecordid>2799172261</sourcerecordid><originalsourceid>FETCH-LOGICAL-c393t-4b14def8c489a0613a23b9115494f640e66e27b0884841ae42f9d4b84547ad193</originalsourceid><addsrcrecordid>eNqFkE1Lw0AQhhdRbE39CUrBSz1EZ3Y3-3GSUloVChY_wNuySTaQ0ja6mwj-e5O29uDF01yeeeedh5ALhBsEFLcvgBxiIZkYUXYNIFHGeET6yCWPEy7fj0n_gPTIWQhLAOACklPSYxIYCsX6ZLCYLmbj56GthxQG5KSwq-DO9zMib7Pp6-Qhnj_dP07G8zhjmtUxT5HnrlAZV9qCQGYpSzViwjUvBAcnhKMyBaW44mgdp4XOeap4W8vmqFlERrvcD199Ni7UZl2GzK1WduOqJhgqtUZJaRsdkas_6LJq_KZt11FCaUjaByOS7KjMVyF4V5gPX66t_zYIptNltrpM58JQZra6TJd-uU9v0rXLD1u_flrgbge4VsdX6bwJWek2mctL77La5FX5z4kfCelzoQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2796890567</pqid></control><display><type>article</type><title>PEPFAR at 20</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><source>ProQuest Central UK/Ireland</source><creator>Webster, Paul</creator><creatorcontrib>Webster, Paul</creatorcontrib><description>First proposed by President Bush in January, 2003, and approved by Congress in late May, 2003, PEPFAR has since received more than $100 billion in US Government support. According to the US State Department, over a dozen countries with high disease burden have HIV under control thanks to PEPFAR. (Photo by Paul Botes / AFP) (Photo by PAUL BOTES/AFP via Getty Images) Paul Botes/Getty Images Jennifer Kates, Director of Global Health and HIV Policy at the Kaiser Family Foundation, Washington DC, says that data from two studies she coauthored show a “strong, significant association between PEPFAR and progress in many health indicators beyond HIV”. González-Pier describes PEPFAR now as a “maintenance programme” that should increasingly expect to share the stage with other US international health priorities including climate change, global health security, and pandemic control. “Because PEPFAR proved itself so successfully, cross-cutting lessons are now being drawn from it for a new set of US health diplomacy concerns”, says González-Pier.</description><identifier>ISSN: 0140-6736</identifier><identifier>EISSN: 1474-547X</identifier><identifier>DOI: 10.1016/S0140-6736(23)00717-1</identifier><identifier>PMID: 37031683</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Acquired immune deficiency syndrome ; Acquired Immunodeficiency Syndrome - epidemiology ; Acquired Immunodeficiency Syndrome - prevention & control ; AIDS ; Bush, George W ; Climate change ; COVID-19 ; Cross cutting ; Global health ; HIV ; HIV Infections ; Human immunodeficiency virus ; Humans ; Infectious diseases ; Medical research ; Public health</subject><ispartof>The Lancet (British edition), 2023-04, Vol.401 (10383), p.1145-1146</ispartof><rights>2023 Elsevier Ltd</rights><rights>2023. Elsevier Ltd</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c393t-4b14def8c489a0613a23b9115494f640e66e27b0884841ae42f9d4b84547ad193</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.proquest.com/docview/2796890567?pq-origsite=primo$$EHTML$$P50$$Gproquest$$H</linktohtml><link.rule.ids>315,781,785,3551,27928,27929,45999,64389,64391,64393,72473</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37031683$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Webster, Paul</creatorcontrib><title>PEPFAR at 20</title><title>The Lancet (British edition)</title><addtitle>Lancet</addtitle><description>First proposed by President Bush in January, 2003, and approved by Congress in late May, 2003, PEPFAR has since received more than $100 billion in US Government support. According to the US State Department, over a dozen countries with high disease burden have HIV under control thanks to PEPFAR. (Photo by Paul Botes / AFP) (Photo by PAUL BOTES/AFP via Getty Images) Paul Botes/Getty Images Jennifer Kates, Director of Global Health and HIV Policy at the Kaiser Family Foundation, Washington DC, says that data from two studies she coauthored show a “strong, significant association between PEPFAR and progress in many health indicators beyond HIV”. González-Pier describes PEPFAR now as a “maintenance programme” that should increasingly expect to share the stage with other US international health priorities including climate change, global health security, and pandemic control. “Because PEPFAR proved itself so successfully, cross-cutting lessons are now being drawn from it for a new set of US health diplomacy concerns”, says González-Pier.</description><subject>Acquired immune deficiency syndrome</subject><subject>Acquired Immunodeficiency Syndrome - epidemiology</subject><subject>Acquired Immunodeficiency Syndrome - prevention & control</subject><subject>AIDS</subject><subject>Bush, George W</subject><subject>Climate change</subject><subject>COVID-19</subject><subject>Cross cutting</subject><subject>Global health</subject><subject>HIV</subject><subject>HIV Infections</subject><subject>Human immunodeficiency virus</subject><subject>Humans</subject><subject>Infectious diseases</subject><subject>Medical research</subject><subject>Public health</subject><issn>0140-6736</issn><issn>1474-547X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNqFkE1Lw0AQhhdRbE39CUrBSz1EZ3Y3-3GSUloVChY_wNuySTaQ0ja6mwj-e5O29uDF01yeeeedh5ALhBsEFLcvgBxiIZkYUXYNIFHGeET6yCWPEy7fj0n_gPTIWQhLAOACklPSYxIYCsX6ZLCYLmbj56GthxQG5KSwq-DO9zMib7Pp6-Qhnj_dP07G8zhjmtUxT5HnrlAZV9qCQGYpSzViwjUvBAcnhKMyBaW44mgdp4XOeap4W8vmqFlERrvcD199Ni7UZl2GzK1WduOqJhgqtUZJaRsdkas_6LJq_KZt11FCaUjaByOS7KjMVyF4V5gPX66t_zYIptNltrpM58JQZra6TJd-uU9v0rXLD1u_flrgbge4VsdX6bwJWek2mctL77La5FX5z4kfCelzoQ</recordid><startdate>20230408</startdate><enddate>20230408</enddate><creator>Webster, Paul</creator><general>Elsevier Ltd</general><general>Elsevier Limited</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>0TT</scope><scope>0TZ</scope><scope>0U~</scope><scope>3V.</scope><scope>7QL</scope><scope>7QP</scope><scope>7RV</scope><scope>7TK</scope><scope>7U7</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88C</scope><scope>88E</scope><scope>88G</scope><scope>88I</scope><scope>8AF</scope><scope>8AO</scope><scope>8C1</scope><scope>8C2</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AN0</scope><scope>ASE</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BEC</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FPQ</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K6X</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>KB~</scope><scope>LK8</scope><scope>M0R</scope><scope>M0S</scope><scope>M0T</scope><scope>M1P</scope><scope>M2M</scope><scope>M2O</scope><scope>M2P</scope><scope>M7N</scope><scope>M7P</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>S0X</scope><scope>7X8</scope></search><sort><creationdate>20230408</creationdate><title>PEPFAR at 20</title><author>Webster, Paul</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c393t-4b14def8c489a0613a23b9115494f640e66e27b0884841ae42f9d4b84547ad193</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Acquired immune deficiency syndrome</topic><topic>Acquired Immunodeficiency Syndrome - epidemiology</topic><topic>Acquired Immunodeficiency Syndrome - prevention & control</topic><topic>AIDS</topic><topic>Bush, George W</topic><topic>Climate change</topic><topic>COVID-19</topic><topic>Cross cutting</topic><topic>Global health</topic><topic>HIV</topic><topic>HIV Infections</topic><topic>Human immunodeficiency virus</topic><topic>Humans</topic><topic>Infectious diseases</topic><topic>Medical research</topic><topic>Public health</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Webster, Paul</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>News PRO</collection><collection>Pharma and Biotech Premium PRO</collection><collection>Global News & ABI/Inform Professional</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Nursing & Allied Health Database</collection><collection>Neurosciences Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Healthcare Administration Database (Alumni)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Psychology Database (Alumni)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Lancet Titles</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>British Nursing Database</collection><collection>British Nursing Index</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>eLibrary</collection><collection>Proquest Central</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>British Nursing Index (BNI) (1985 to Present)</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>British Nursing Index</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>ProQuest Newsstand Professional</collection><collection>ProQuest Biological Science Collection</collection><collection>Consumer Health Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Healthcare Administration Database</collection><collection>Medical Database</collection><collection>Psychology Database</collection><collection>Research Library</collection><collection>Science Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>SIRS Editorial</collection><collection>MEDLINE - Academic</collection><jtitle>The Lancet (British edition)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Webster, Paul</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>PEPFAR at 20</atitle><jtitle>The Lancet (British edition)</jtitle><addtitle>Lancet</addtitle><date>2023-04-08</date><risdate>2023</risdate><volume>401</volume><issue>10383</issue><spage>1145</spage><epage>1146</epage><pages>1145-1146</pages><issn>0140-6736</issn><eissn>1474-547X</eissn><abstract>First proposed by President Bush in January, 2003, and approved by Congress in late May, 2003, PEPFAR has since received more than $100 billion in US Government support. According to the US State Department, over a dozen countries with high disease burden have HIV under control thanks to PEPFAR. (Photo by Paul Botes / AFP) (Photo by PAUL BOTES/AFP via Getty Images) Paul Botes/Getty Images Jennifer Kates, Director of Global Health and HIV Policy at the Kaiser Family Foundation, Washington DC, says that data from two studies she coauthored show a “strong, significant association between PEPFAR and progress in many health indicators beyond HIV”. González-Pier describes PEPFAR now as a “maintenance programme” that should increasingly expect to share the stage with other US international health priorities including climate change, global health security, and pandemic control. “Because PEPFAR proved itself so successfully, cross-cutting lessons are now being drawn from it for a new set of US health diplomacy concerns”, says González-Pier.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>37031683</pmid><doi>10.1016/S0140-6736(23)00717-1</doi><tpages>2</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0140-6736 |
| ispartof | The Lancet (British edition), 2023-04, Vol.401 (10383), p.1145-1146 |
| issn | 0140-6736 1474-547X |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2799172261 |
| source | MEDLINE; Access via ScienceDirect (Elsevier); ProQuest Central UK/Ireland |
| subjects | Acquired immune deficiency syndrome Acquired Immunodeficiency Syndrome - epidemiology Acquired Immunodeficiency Syndrome - prevention & control AIDS Bush, George W Climate change COVID-19 Cross cutting Global health HIV HIV Infections Human immunodeficiency virus Humans Infectious diseases Medical research Public health |
| title | PEPFAR at 20 |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-17T05%3A41%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=PEPFAR%20at%2020&rft.jtitle=The%20Lancet%20(British%20edition)&rft.au=Webster,%20Paul&rft.date=2023-04-08&rft.volume=401&rft.issue=10383&rft.spage=1145&rft.epage=1146&rft.pages=1145-1146&rft.issn=0140-6736&rft.eissn=1474-547X&rft_id=info:doi/10.1016/S0140-6736(23)00717-1&rft_dat=%3Cproquest_cross%3E2799172261%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2796890567&rft_id=info:pmid/37031683&rft_els_id=S0140673623007171&rfr_iscdi=true |